Fat loss pill that can help you ‘lose weight AND tone up' set to rival jabs
FIT NOT FLABBY Fat loss pill that can help you 'lose weight AND tone up' set to rival jabs
A PILL to make you buff is a step nearer to reality as inventors move onto the next phase of human trials.
Scientists say the drug, currently known as ATR-258, can burn off fat but save muscle.
1
An experimental pill could burn fat without losing muscle (stock image)
Credit: Alamy
It would overcome an issue with fat jabs such as Mounjaro which shrink muscle as well as flab.
Advertisement
This can leave people weak and make them look more skinny or saggy.
Preserving muscle while fat burns off could help slimmers stay toned, as well as boosting their health.
Professor Tore Bengtsson, founder of manufacturer Atrogi, said: 'This pill can actively reshape body composition, reducing fat while preserving muscle mass, all without requiring dietary restriction.
'That's unprecedented.'
Advertisement
Large human trial to test effects
The drug was invented to treat obesity and type 2 diabetes.
Results of the first phase trial, on 48 patients, were published in the journal Cell and showed it was safe for humans to take.
Prof Bengtsson, also of Stockholm University, now plans to trial it on a bigger group of overweight people to see if it works as well as it did in animal studies.
It functions by triggering the metabolism in the muscles, activating them to burn more fat.
Advertisement
This is different to injections like Ozempic, which use hormones in the brain to banish hunger.
Two thirds of adults in the UK are overweight or obese and the issue has rocketed since the 1990s.
Prof Bengtsson said: 'Our results point to a future where we can improve metabolic health without losing muscle mass.
'Muscles are important in both type 2 diabetes and obesity, and muscle mass is also directly correlated with life expectancy.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Trial finds weight loss drug taken monthly helps people lose 20% of body weight
A new trial has found that a weight loss drug taken monthly helps people lose 20 percent of their body weight. Weight loss medications such as Ozempic, Wegovy and Mounjaro have become popular and now there's a new GLP-1 drug, MariTide, being tested that could be competitive in the market. MariTide, from the drug maker Amgen, is different from the other weight loss drugs as it also has a monoclonal antibody, which allows the medication to stay in the body longer, NBC News health and medical reporter Berkeley Lovelace Jr. explained in an article published Monday. The article dives into a new trial published in The New England Journal of Medicine. Researchers analyzed nearly 600 participants, who were broken up into those with both Type 2 diabetes and obesity and those with obesity. The trial found that those with obesity alone who were treated with MariTide lost up to about 20 percent of their body weight, on average, after 52 weeks. Those with obesity alone who didn't take the MariTide only lost up to 2.6 percent of their body weight, on average. Participants who had diabetes and obesity lost up to 17 percent of their body weight, on average, while taking MariTide, according to researchers. Those with both diseases who weren't on MariTide lost up to 1.4 percent of their body weight, on average. Ozempic and similar drugs can help patients lose 15 to 20 percent of their body weight, according to Columbia University's Department of Surgery. Ozempic and other GLP-1 medications are taken weekly, but MariTide only needs to be taken monthly, making it more convenient for patients. 'It's always just easier for patients to only have to take something once per month,' Dr. Michelle Ponder, an assistant professor of medicine at Duke University School of Medicine in North Carolina, told Lovelace. Ponder, who wasn't a part of the MariTide trial, added: 'A lot of patients we see in endocrinology are diabetes patients, and so they'd be taking multiple shots of insulin per day. And so, every last shot matters, even if it's three less shots per month.' MariTide researchers said gastrointestinal issues were 'common' with the drug, but Lovelace pointed out that the drug's side effects were similar to those of other GLP-1 medications.
Daily Mirror
5 hours ago
- Daily Mirror
GPs' strict rules for prescribing weight loss jab explained
GPs are now able to prescribe Mounjaro injections, but only if patients meet strict guidelines NHS England has announced that GPs will now be able to prescribe Mounjaro injections. Originally licensed for type 2 diabetes treatment, the medication's use as a weight loss aid stems from its appetite-suppressing properties. The health service aims to make these injections widely available, but this is a long-term objective. Starting on Monday, a very limited group of people will be able to get prescriptions for it through their GP. Currently, two criteria must be met to qualify for the prescription. Firstly, a BMI of 40 or over is required, however, if you're from a minority ethnic background, you may be eligible with a BMI of 37.5 or over. Additionally, you'll need to have been diagnosed with four out of the following five conditions: Type 2 diabetes High blood pressure Heart and vascular disease High cholesterol Obstructive sleep apnoea In this initial rollout, it's expected that 220,000 people will be eligible and receive Mounjaro through the NHS in the next three years, according to the Guardian. Previously, patients needed to use special weight loss services to access the medication. As weight loss medication became mainstream news, GP surgeries have reported being overwhelmed with requests for the injections. With these criteria now in the open, GPs are urging people not to approach their local surgery unless they meet the eligibility requirements, according to the BBC. BMI is calculated by comparing your height and weight, with ethnicity factored in for certain risk factors. It has faced criticism for not accounting for muscle mass, which could skew results, but remains the most common method for assessing obesity in healthcare. The NHS provides a complimentary BMI calculator online here. According to this tool, a BMI between 18.5 and 25 is deemed healthy, below 18.5 is underweight, 25 to 30 is overweight, and over 30 is considered obese. The NHS tool also suggests "next steps" for those whose BMI falls outside the healthy range. Even if you are eligible for the jabs, the early days of this rollout could lead to some hiccups as experts have already warned the supply set aside for GP prescriptions won't be enough to satisfy demand. Mounjaro also requires monthly follow-ups, demanding significant time and effort from medical professionals. As a result, GP surgeries will likely be strategising to ensure they don't exceed their capacity. In Wales, the government is deliberating on a primary care rollout, with the injections presently accessible only via specialist weight management services. Northern Ireland, meanwhile, is implementing a regional obesity management service. For people who don't qualify or live in regions where GPs aren't offering the treatment, Dr Xand offered reassurance on Morning Live: "If you think these drugs would help but you don't meet the criteria, I think it's worth saying there are lots of drugs in the pipeline, it is very likely that the price can come down. "It can be frustrating to have to wait. But I think over the next few years, the picture is optimistic for people who want these drugs."
Medical News Today
7 hours ago
- Medical News Today
Can Ozempic cause mood swings?
Ozempic is a brand-name injection prescribed to help manage type 2 diabetes and certain other associated conditions. It's possible that Ozempic can cause changes in mood as a side effect. However, the mechanism by which this medication can cause shifts in mood is not fully understood, but it may involve changes in brain chemistry and hormone you are taking Ozempic and are experiencing changes in mood, some other factors to consider include:whether you have a history of mental health conditions such as anxiety or depressionweight loss (a common side effect of Ozempic) can contribute to mood changeschanges in mood may be more common when you first start taking OzempicIf you experience mood changes during treatment with Ozempic, talk with your doctor. Does Ozempic cause depression?It's possible that Ozempic can increase the risk of certain mental health conditions such as depression, anxiety, and suicidal thoughts. However, more research is needed to find the link between depression and treatment with contains the active ingredient semaglutide and belongs to the glucagon-like peptide-1 (GLP-1) agonists drug class. This drug is commonly prescribed for the management of type 2 FDA is evaluating reports of suicidal thoughts and actions in people taking GLP-1s. People taking GLP-1s can ask their doctor to monitor any changes in mood or you have concerning changes in mood while using Ozempic, talk with your doctor. They may be able to adjust your dosage or recommend an alternative drug that is right for Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.
